Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Mini Review
  • Published:

Explosion of autoimmune diseases and the mosaic of old and novel factors

Abstract

In recent decades, an enormous effort has been made to elucidate the pathogenesis of autoimmune and autoinflammatory diseases. Autoimmunity is a multifactorial process in which genetic, immunological, environmental and hormonal factors play in concert, together representing what was termed years ago the ‘mosaic of autoimmunity’. To date, more than 80 systemic and organ-specific autoimmune diseases have been defined, and their cumulative burden is substantial, both medically and financially. Furthermore, the burden of autoimmune and autoinflammatory diseases is rising, making these diseases a ubiquitous global phenomenon that is predicted to further increase in the coming decades. In this issue of the journal, additional aspects of autoimmunity are detailed. Immune dysregulation and loss of self-tolerance are the cornerstones of autoimmunity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Arnson Y, Shoenfeld Y, Amital H . Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34: J258–J265.

    Article  CAS  PubMed  Google Scholar 

  2. Berkun Y, Padeh S . Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 2010; 9: A319–A324.

    Article  PubMed  Google Scholar 

  3. Bhat A, Naguwa S, Cheema G, Gershwin ME . The epidemiology of transverse myelitis. Autoimmun Rev 2010; 9: A395–A399.

    Article  PubMed  Google Scholar 

  4. Biggioggero M, Meroni PL . The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev 2010; 9: A299–A304.

    Article  PubMed  Google Scholar 

  5. Borchers AT, Naguwa SM, Keen CL, Gershwin ME . The implications of autoimmunity and pregnancy. J Autoimmun 2010; 34: J287–J299.

    Article  CAS  PubMed  Google Scholar 

  6. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME . The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010; 9: A277–A287.

    Article  CAS  PubMed  Google Scholar 

  7. Borchers AT, Uibo R, Gershwin ME . The geoepidemiology of type 1 diabetes. Autoimmun Rev 2010; 9: A355–A365.

    Article  PubMed  Google Scholar 

  8. Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y . Epigenetics and autoimmunity. J Autoimmun 2010; 34: J207–J219.

    Article  CAS  PubMed  Google Scholar 

  9. Chandran V, Raychaudhuri SP . Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010; 34: J314–J321.

    Article  CAS  PubMed  Google Scholar 

  10. Chang C . The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 2010; 34: J234–J246.

    Article  CAS  PubMed  Google Scholar 

  11. Chang C, Gershwin ME . Drugs and autoimmunity—a contemporary review and mechanistic approach. J Autoimmun 2010; 34: J266–J275.

    Article  CAS  PubMed  Google Scholar 

  12. Chen M, Daha MR, Kallenberg CG . The complement system in systemic autoimmune disease. J Autoimmun 2010; 34: J276–J286.

    Article  CAS  PubMed  Google Scholar 

  13. Chen M, Kallenberg CG . The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev 2010; 9: A293–A298.

    Article  CAS  PubMed  Google Scholar 

  14. Deane S, Teuber SS, Gershwin ME . The geoepidemiology of immune thrombocytopenic purpura. Autoimmun Rev 2010; 9: A342–A349.

    Article  PubMed  Google Scholar 

  15. Ehrenfeld M . Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 2010; 9: A325–A329.

    Article  PubMed  Google Scholar 

  16. Hemminki K, Li X, Sundquist J, Sundquist K . The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun 2010; 34: J307–J313.

    Article  CAS  PubMed  Google Scholar 

  17. Hoffmann MH, Trembleau S, Muller S, Steiner G . Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun 2010; 34: J178–J206.

    Article  CAS  PubMed  Google Scholar 

  18. Invernizzi P . Geoepidemiology of autoimmune liver diseases. J Autoimmun 2010; 34: J300–J306.

    Article  CAS  PubMed  Google Scholar 

  19. Lambert JF, Nydegger UE . Geoepidemiology of autoimmune hemolytic anemia. Autoimmun Rev 2010; 9: A350–A354.

    Article  CAS  PubMed  Google Scholar 

  20. Leung PS, Shu SA, Kenny TP, Wu PY, Tao MH . Development and validation of gene therapies in autoimmune diseases: epidemiology to animal models. Autoimmun Rev 2010; 9: A400–A405.

    Article  CAS  PubMed  Google Scholar 

  21. Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME . Definition of human autoimmunity–autoantibodies versus autoimmune disease. Autoimmun Rev 2010; 9: A259–A266.

    Article  CAS  PubMed  Google Scholar 

  22. Logan I, Bowlus CL . The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 2010; 9: A372–A378.

    Article  PubMed  Google Scholar 

  23. Mackay IR . Travels and travails of autoimmunity: a historical journey from discovery to rediscovery. Autoimmun Rev 2010; 9: A251–A258.

    Article  CAS  PubMed  Google Scholar 

  24. Maverakis E, Miyamura Y, Bowen MP, Correa G, Ono Y, Goodarzi H . Light, including ultraviolet. J Autoimmun 2010; 34: J247–J257.

    Article  CAS  PubMed  Google Scholar 

  25. Mavragani CP, Moutsopoulos HM . The geoepidemiology of Sjogren's syndrome. Autoimmun Rev 2010; 9: A305–A310.

    Article  PubMed  Google Scholar 

  26. Meyer A, Levy Y . Chapter 33: geoepidemiology of myasthenia gravis. Autoimmun Rev 2010; 9: A383–A386.

    Article  PubMed  Google Scholar 

  27. Meyer N, Misery L . Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev 2010; 9: A379–A382.

    Article  CAS  PubMed  Google Scholar 

  28. Milo R, Kahana E . Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010; 9: A387–A394.

    Article  CAS  PubMed  Google Scholar 

  29. Powell JJ, Faria N, Thomas-McKay E, Pele LC . Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun 2010; 34: J226–J233.

    Article  CAS  PubMed  Google Scholar 

  30. Prieto S, Grau JM . The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 2010; 9: A330–A334.

    Article  PubMed  Google Scholar 

  31. Ranque B, Mouthon L . Geoepidemiology of systemic sclerosis. Autoimmun Rev 2010; 9: A311–A318.

    Article  PubMed  Google Scholar 

  32. Round JL, O'Connell RM, Mazmanian SK . Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 2010; 34: J220–J225.

    Article  CAS  PubMed  Google Scholar 

  33. Sands J, Tuscano JM . Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders. Autoimmun Rev 2010; 9: A335–A341.

    Article  PubMed  Google Scholar 

  34. Segelmark M, Hellmark T . Autoimmune kidney diseases. Autoimmun Rev 2010; 9: A366–A371.

    Article  CAS  PubMed  Google Scholar 

  35. Selmi C . The worldwide gradient of autoimmune conditions. Autoimmun Rev 2010; 9: A247–A250.

    Article  PubMed  Google Scholar 

  36. Selmi C, Tsuneyama K . Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 2010; 9: A267–A270.

    Article  CAS  PubMed  Google Scholar 

  37. Shapira Y, Agmon-Levin N, Shoenfeld Y . Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010; 34: J168–J177.

    Article  CAS  PubMed  Google Scholar 

  38. Stojanovich L . Stress and autoimmunity. Autoimmun Rev 2010; 9: A271–A276.

    Article  CAS  PubMed  Google Scholar 

  39. Tobon GJ, Youinou P, Saraux A . The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 2010; 9: A288–A292.

    Article  CAS  PubMed  Google Scholar 

  40. Tomer Y . Hepatitis C and interferon induced thyroiditis. J Autoimmun 2010; 34: J322–J326.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Youinou P, Pers JO, Gershwin ME, Shoenfeld Y . Geo-epidemiology and autoimmunity. J Autoimmun 2010; 34: J163–J167.

    Article  CAS  PubMed  Google Scholar 

  42. Zeki AA, Schivo M, Chan AL, Hardin KA, Kenyon NJ, Albertson TE et al. Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun 2010; 34: J327–J338.

    Article  CAS  PubMed  Google Scholar 

  43. Liu X, Invernizzi P, Lu Y, Kosoy R, Bianchi I, Podda M et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010; 42: 658–660.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Oliveira LC, Porta G, Marin ML, Bittencourt PL, Kalil J, Goldberg AC . Autoimmune hepatitis, HLA and extended haplotypes. Autoimmun Rev 2010; in press.

  45. Tomer Y . Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 2010; 20: 715–725.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y . Infections and autoimmunity—friends or foes? Trends Immunol 2009; 30: 409–414.

    Article  CAS  PubMed  Google Scholar 

  47. Agmon-Levin N, Katz BS, Shoenfeld Y . Infection and primary biliary cirrhosis. Isr Med Assoc J 2009; 11: 112–115.

    PubMed  Google Scholar 

  48. Agmon-Levin N, Ram M, Barzilai O, Porat-Katz BS, Parikman R, Selmi C et al. Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun 2009; 32: 261–266.

    Article  CAS  PubMed  Google Scholar 

  49. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y . Vaccines and autoimmunity. Nat Rev Rheumatol 2009; 5: 648–652.

    Article  PubMed  Google Scholar 

  50. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y . Adjuvants and autoimmunity. Lupus 2009; 18: 1217–1225.

    Article  CAS  PubMed  Google Scholar 

  51. Selmi C, Cocchi CA, Zuin M, Gershwin ME . The chemical pathway to primary biliary cirrhosis. Clin Rev Allergy Immunol 2009; 36: 23–29.

    Article  PubMed  Google Scholar 

  52. Shoenfeld Y, Agmon-Levin N . ‘ASIA’—autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2010; in press.

  53. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases—2008. Isr Med Assoc J 2008; 10: 8–12.

    PubMed  Google Scholar 

  54. Praprotnik S, Agmon-Levin N, Porat-Katz BS, Blank M, Meroni PL, Cervera R et al. Prolactin's role in the pathogenesis of the antiphospholipid syndrome. Lupus 2010; 19: 1515–1519.

    Article  CAS  PubMed  Google Scholar 

  55. Agmon-Levin N, Blank M, Zandman-Goddard G, Orbach H, Meroni PL, Tincani A et al. Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis 2010; 70: 145–150.

    Article  PubMed  Google Scholar 

  56. Amital H, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010; 69: 1155–1157.

    Article  CAS  PubMed  Google Scholar 

  57. Shoenfeld N, Amital H, Shoenfeld Y . The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol 2009; 5: 99–105.

    Article  CAS  PubMed  Google Scholar 

  58. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010; 9: 709–715.

    Article  CAS  PubMed  Google Scholar 

  59. Gershwin ME, Goetzl EJ, Steinberg AD . Cyclophosphamide: use in practice. Ann Intern Med 1974; 80: 531–540.

    Article  CAS  PubMed  Google Scholar 

  60. Mackay IR . The etiopathogenesis of autoimmunity. Semin Liver Dis 2005; 25: 239–250.

    Article  PubMed  Google Scholar 

  61. Martin PI, Malizia AI, Rewald E . A propos time and autoimmunity. Clin Rev Allergy Immunol 2008; 34: 380–384.

    Article  PubMed  Google Scholar 

  62. Tonutti E, Visentini D, Bizzaro N . Interpretative comments on autoantibody tests. Autoimmun Rev 2007; 6: 341–346.

    Article  CAS  PubMed  Google Scholar 

  63. Bizzaro N, Tozzoli R, Shoenfeld Y . Are we at a stage to predict autoimmune rheumatic diseases? Arthritis Rheum 2007; 56: 1736–1744.

    Article  CAS  PubMed  Google Scholar 

  64. Hershko AY, Naparstek Y . Autoimmunity in the era of genomics and proteomics. Autoimmun Rev 2006; 5: 230–233.

    Article  CAS  PubMed  Google Scholar 

  65. Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME . The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008; 31: 325–330.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yehuda Shoenfeld.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agmon-Levin, N., Lian, Z. & Shoenfeld, Y. Explosion of autoimmune diseases and the mosaic of old and novel factors. Cell Mol Immunol 8, 189–192 (2011). https://doi.org/10.1038/cmi.2010.70

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cmi.2010.70

Keywords

This article is cited by

Search

Quick links